Steve Damment

Fondateur chez

Aluztura Bio Ltd.

Health Technology

Commercial Services

Consumer Services

Profil

Steve Damment is the founder of Aluztura Bio Ltd. which is founded in 2014, where he holds the title of Chief Science Officer.
He held the position of Senior Vice President-Biosciences at Shire Plc from 2000 to 2013 and at GSK Plc from 1982 to 1999.
He also held the position of Executive Vice President-Research & Development at Biodexa Pharmaceuticals Plc from 2018 to 2021.
Dr. Damment received his undergraduate degree from The University of Liverpool.

Postes actifs de Steve Damment

Sociétés	Poste	Début
Aluztura Bio Ltd.	Fondateur	01/01/2014

Tous les postes actifs de Steve Damment

Anciens postes connus de Steve Damment

Sociétés	Poste	Fin
BIODEXA PHARMACEUTICALS PLC	Directeur Technique/Scientifique/R&D	30/09/2021
Shire Plc /Old/ Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals	Corporate Officer/Principal	01/12/2013
GSK PLC	Corporate Officer/Principal	01/12/1999

Voir l'expérience en détail de Steve Damment

Formation de Steve Damment

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Steve Damment

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Shire Plc /Old/ Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals	Commercial Services
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
The University of Liverpool The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Biodexa Pharmaceuticals Plc Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines	Health Technology
Aluztura Bio Ltd.